Table 2 Blood biochemistry, CD4/8 cell ratio and PBL telomere length in study participants
yCtr (IQR) | ySCI (IQR) | oCtr (IQR) | oSCI (IQR) | yCtr-oCtr (p-value) | ySCI-oSCI (p-value) | yCtr-ySCI (p-value) | oCtr-oSCI (p-value) | |
|---|---|---|---|---|---|---|---|---|
Total prot. (mg/ml) | 71.0 (4) | 66.5 (7) | 70.0 (5) | 68.0 (7) | 0.06 ↓ | 0.16 ↔ | <.001 | 0.30 |
pIgG (mg/ml) | 10.7 (4) | 9.8 (3) | 10.2 (4) | 9.7 (4) | 0.28 ↔ | 0.85 ↔ | 0.30 | 0.82 |
IL-2 (pg/ml) | 5.5 (3) | 6.2 (5) | 6.0 (2) | 6.1 (2) | 0.12 ↔ | 0.27 ↔ | <.01 | 0.70 |
IL-4 (pg/ml) | 1.5 (0.6) | 1.3 (0.2) | 2.0 (1.1) | 1.4 (0.5) | <.01 ↑ | 0.14 ↔ | <.01 | <.001 |
IL-10 (pg/ml) | 3.6 (3) | 2.9 (3) | 5.0 (4) | 3.9 (3) | <.05 ↑ | 0.12 ↔ | 0.25 | 0.19 |
G-CSF (pg/ml) | 26.3 (7) | 25.0 (5) | 31.0 (10) | 26.9 (7) | <.05 ↑ | <.05 ↑ | <.05 | 0.05 |
GM-CSF (pg/ml) | 67 (25) | 97 (50) | 71 (30) | 72 (35) | 0.14 ↔ | <.01 ↓ | <.001 | 0.44 |
MCP-1 (pg/ml) | 138 (28) | 131 (20) | 153 (43) | 134 (27) | <.05 ↑ | 0.29 ↔ | 0.10 | <.01 |
CD4/8 (ratio) | 2.4 (1.4) | 2.1 (2.2) | 3.0 (2.7) | 2.9 (2.7) | <.05 ↑ | 0.08 ↑ | 0.69 | 0.71 |
Telomere length PBL (Norm. to yCtr) | 1 (0.5) | 1.0 (0.4) | 0.8 (0.3) | 0.9 (0.3) | <.05 ↓ | 0.09↓ | 0.44 | 0.07 |